Cargando…
Efectividad de mepolizumab y benralizumab en una cohorte de pacientes con asma grave eosinofílico en vida real
INTRODUCTION: Mepolizumab is a monoclonal antibody that inhibits circulating interleukin 5 (IL-5). Benralizumab binds to the alpha subunit of the IL-5 receptor, inducing the direct elimination of eosinophils and basophils. The aim of this study was to evaluate their effectiveness in our routine clin...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369559/ https://www.ncbi.nlm.nih.gov/pubmed/37497072 http://dx.doi.org/10.1016/j.opresp.2021.100103 |